BACKGROUND: Portal vein (PV) resection is used increasingly in pancreatic resections. There is no agreed policy regarding anticoagulation. METHODS: A systematic review was performed to compare studies with an anticoagulation policy (AC+) to no anticoagulation policy (AC-) after venous resection. RESULTS: There were eight AC+ studies (n = 266) and five AC- studies (n = 95). The AC+ studies included aspirin, clopidogrel, heparin or warfarin. Only 50% of patients in the AC+ group received anticoagulation. There were more prosthetic grafts in the AC+ group (30 versus 2, Fisher's exact P < 0.001). The overall morbidity and mortality was similar in both groups. Early PV thrombosis (EPVT) was similar in the AC+ group and the AC- group (7%, versus 3%, Fisher's exact P = 0.270) and was associated with a high mortality (8/20, 40%). When prosthetic grafts were excluded there was no difference in the incidence of EPVT between both groups (1% vs 2%, Fisher's exact test P = 0.621). CONCLUSION: There is significant heterogeneity in the use of anticoagulation after PV resection. Overall morbidity, mortality and EPVT in both groups were similar. EPVT has a high associated mortality. While we have been unable to demonstrate a benefit for anticoagulation, the incidence of EPVT is low in the absence of prosthetic grafts.
BACKGROUND: Portal vein (PV) resection is used increasingly in pancreatic resections. There is no agreed policy regarding anticoagulation. METHODS: A systematic review was performed to compare studies with an anticoagulation policy (AC+) to no anticoagulation policy (AC-) after venous resection. RESULTS: There were eight AC+ studies (n = 266) and five AC- studies (n = 95). The AC+ studies included aspirin, clopidogrel, heparin or warfarin. Only 50% of patients in the AC+ group received anticoagulation. There were more prosthetic grafts in the AC+ group (30 versus 2, Fisher's exact P < 0.001). The overall morbidity and mortality was similar in both groups. Early PV thrombosis (EPVT) was similar in the AC+ group and the AC- group (7%, versus 3%, Fisher's exact P = 0.270) and was associated with a high mortality (8/20, 40%). When prosthetic grafts were excluded there was no difference in the incidence of EPVT between both groups (1% vs 2%, Fisher's exact test P = 0.621). CONCLUSION: There is significant heterogeneity in the use of anticoagulation after PV resection. Overall morbidity, mortality and EPVT in both groups were similar. EPVT has a high associated mortality. While we have been unable to demonstrate a benefit for anticoagulation, the incidence of EPVT is low in the absence of prosthetic grafts.
Authors: Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans Journal: J Gastrointest Surg Date: 2004-12 Impact factor: 3.452
Authors: Thomas J Howard; Nicholas Villanustre; Seth A Moore; John DeWitt; Julia LeBlanc; Dean Maglinte; Lee McHenry Journal: J Gastrointest Surg Date: 2003-12 Impact factor: 3.267
Authors: A N Krepline; K K Christians; K Duelge; A Mahmoud; P Ritch; B George; B A Erickson; W D Foley; E J Quebbeman; K K Turaga; F M Johnston; T C Gamblin; D B Evans; S Tsai Journal: J Gastrointest Surg Date: 2014-09-17 Impact factor: 3.452
Authors: Dyre Kleive; Audun E Berstad; Caroline S Verbeke; Sven P Haugvik; Ivar P Gladhaug; Pål-Dag Line; Knut J Labori Journal: HPB (Oxford) Date: 2016-06-20 Impact factor: 3.647
Authors: Monica M Dua; Thuy B Tran; Jill Klausner; Kim J Hwa; George A Poultsides; Jeffrey A Norton; Brendan C Visser Journal: HPB (Oxford) Date: 2015-07-30 Impact factor: 3.647
Authors: Katharina Marsoner; Rainer Langeder; Dora Csengeri; Gottfried Sodeck; Hans Jörg Mischinger; Peter Kornprat Journal: Wien Klin Wochenschr Date: 2016-06-30 Impact factor: 1.704
Authors: Kai Siang Chan; Nandhini Srinivasan; Ye Xin Koh; Ek Khoon Tan; Jin Yao Teo; Ser Yee Lee; Peng Chung Cheow; Prema Raj Jeyaraj; Pierce Kah Hoe Chow; London Lucien Peng Jin Ooi; Chung Yip Chan; Alexander Yaw Fui Chung; Brian Kim Poh Goh Journal: PLoS One Date: 2020-11-05 Impact factor: 3.240